New York Employers to Stock Narcan by December 2026

A new state law mandates naloxone availability in specific workplaces starting late next year.

Updated on Oct. 28, 2026 in Substance Abuse

Isometric editorial illustration of a wall-mounted metal medical kit, representing health and safety regulations for New York workplaces. — New York will mandate that employers in specific high-risk worksites stock naloxone kits starting in December 2026 to improve overdose emergency response. AI Illustration. Upload story photo >

Live Poll

Should employers be required to keep overdose reversal medication on-site in your area?

Starting in December 2026, New York will require certain employers to maintain a supply of naloxone, also known as Narcan, at their worksites. This regulation applies to companies already mandated by OSHA to provide first aid kits that are located significant distances from medical facilities.

Why it matters

The measure aims to address the prevalence of substance-related emergencies in professional environments, where overdoses account for as much as one-tenth of all occupational injury deaths nationwide.

One-tenth of all occupational injury deaths in America are caused by drug overdoses. The new requirement applies to workplaces already obligated by OSHA to maintain first aid kits that operate far from immediate medical care.

The players

OSHA

The Occupational Safety and Health Administration is a federal agency responsible for setting and enforcing workplace safety and health standards.

The details

Employers falling under the new state mandate must ensure that naloxone is available on-site to assist in overdose reversals. The regulation targets high-risk work environments where proximity to emergency medical services is insufficient for rapid response.

December 2026: The new New York state law takes effect.

Health Landscape

The law leverages the OSHA first aid kit standard to determine which New York businesses must now carry naloxone on-site. This marks a strategic expansion of workplace safety regulations to address modern public health crises beyond traditional physical injury risks.

Employees at affected New York workplaces may soon have access to life-saving naloxone directly at their job sites. These businesses will be required to maintain these kits to provide immediate intervention during potential overdose emergencies.

The takeaway

Workplaces are increasingly viewed as critical sites for public health interventions given the time-sensitive nature of overdose response. Employers should begin evaluating their current medical supply kits to prepare for the upcoming 2026 compliance deadline.